Review of the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences

Type: Consensus Study
Topics: Biomedical and Health Research
Board: Board on Health Sciences Policy

Activity Description

In response to a request from the National Institutes of Health (NIH), the IOM assembled an expert committee to provide an independent appraisal of and advice on the NIH Clinical and Translational Science Awards (CTSA) Program as it has been implemented by the newly formed National Center for Advancing Translational Sciences (NCATS). The current mission of the CTSA program includes services and infrastructure support for the full continuum of clinical and translational research. The services provided by CTSAs have supported T1 through T4 research, with primary emphasis on support for human subjects research extending from first-in-man and proof-of-concept studies through efficacy and effectiveness studies, and including research on how to achieve community and patient engagement, implementation and dissemination sciences, and behavioral research.

The IOM committee reviewed existing evaluations and available stakeholder input on the program, and sought additional stakeholder input as needed. Based on this assessment, the committee will provide recommendations on the appropriateness of the program’s current mission and overarching goals and whether changes are needed. This study will explore the contributions of the CTSAs in accelerating the development of new therapeutics with consideration given to the role of the CTSA program in facilitating disease-specific research and pediatric research and in enhancing the integration of programs funded by the categorical NIH Institutes and Centers.

For more information

Previous Meetings for this Activity

View All Previous Meetings